Mesulid detailed information:
Mesulid is a popular medicine that is also commonly known under the generic name of Nimesulide. This drug belongs to a wide class of medicines called anti-inflammatory nonsteroidal drugs (NSAID). NSAIDs are well known for their anti-pyretic, anti-inflammatory, and analgesic properties. What makes Mesulid different from the other NSAIDs is that this drug’s functional acidic group is a sulfonanilide. This enables Nimesulide to effectively and rapidly provide the relief of inflammation and pain symptoms that are usually associated with a large variety of medical conditions. This medicine has proven itself to be highly effective especially in the treatment of patients who have not adequately responded to other non-steroidal anti-inflammatory medicines or to extremely sensitive patients who have gastric-intolerance or NSAID-intolerance.
This medicine is a NSAID with analgesic and antipyretic properties and its approved indications are the treatment of acute pain, the symptomatic treatment of osteoarthrosis and primary dysmenorrhoea in adolescents and adults above 12 years old. Nimesulide is among the top 5 non-steroidal anti-inflammatory drugs worldwide. It is usually used for an average short-term treatment in the case of patients who are suffering from any of the following medical conditions: painful extra-articular medical disorders, post-operative dental inflammation and pain, etc. A pain–killing medication Mesulid appears to halt the production of an enzyme that is key to a common form of breast cancer, a new study using tissue cultures suggests. Derivatives of nimesulide stopped the production of aromatase, the enzyme implicated in estrogen-dependent breast cancer.
Mesulid is a sulphonanilide analogue; it is not related to conventional NSAIDs, which usually present a carboxyl or hydroxyl functional group. It shows a superior gastrointestinal safety profile in comparison to other NSAIDs and a low propensity for renal, cardiovascular, skin and hepatic side effects.
For further information about MESULID, consult with your doctor.